the leeds teaching hospitals nhs trust pharmacology in acs overview of the data : practical advice...

17
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : OVERVIEW OF THE DATA : PRACTICAL ADVICE PRACTICAL ADVICE JIM McLENACHAN, JIM McLENACHAN, LEEDS. LEEDS. 25 th January, 2007

Upload: cameron-underwood

Post on 18-Jan-2018

219 views

Category:

Documents


0 download

DESCRIPTION

The Leeds Teaching Hospitals NHS Trust Pharmacology in ACS Anti-platelet agents Anti-thrombin agents Aspirin Clopidogrel Heparin (UFH, LMWH) ?IIb/IIIa antagonists ?Bivalirudin A and E / ward Cath lab ?Heparin ?Bivalirudin

TRANSCRIPT

Page 1: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

PHARMACOLOGY IN ACSPHARMACOLOGY IN ACS

OVERVIEW OF THE DATA : OVERVIEW OF THE DATA : PRACTICAL ADVICE PRACTICAL ADVICE

JIM McLENACHAN,JIM McLENACHAN,LEEDS.LEEDS. 25th January, 2007

Page 2: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

CONFLICT OF INTEREST :

ADVISORY BOARD MEMBER FOR LILLY AND NYCOMED

Page 3: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

Pharmacology in ACSPharmacology in ACSAnti-platelet agents Anti-thrombin agents

AspirinClopidogrel

Heparin(UFH, LMWH)

?IIb/IIIa antagonists

?IIb/IIIa antagonists ?Bivalirudin

A a

nd E

/ w

ard

Cat

h la

b

?Heparin

?Bivalirudin

Page 4: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

Pharmacology in ACSPharmacology in ACS

AspirinUFH

LMWHIIb/IIIa antagonists

Clopidogrel

Bivalirudin

19951996

1999

2004

Page 5: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ADJUNCTIVE THERAPY IN PCIADJUNCTIVE THERAPY IN PCI

45 year old male with chest painECG – T inversion V1 –V6

Troponin raised

Angiogram - 95% LAD stenosis

PCI to LAD

Page 6: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ADJUNCTIVE THERAPY IN PCIADJUNCTIVE THERAPY IN PCI

45 year old male with chest painECG – T inversion V1 –V6

Troponin raised

Angiogram - 95% LAD stenosis

PCI to LAD

AspirinClopidogrelLMWH

?IIb/IIIa inhibitor

UFH

?IIb/IIIainhibitor

Page 7: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ADJUNCTIVE THERAPY IN PCIADJUNCTIVE THERAPY IN PCI

45 year old male with chest painECG – T inversion V1 –V6

Troponin raised

Angiogram - 95% LAD stenosis

PCI to LAD

AspirinClopidogrelLMWH

?IIb/IIIa inhibitor

UFH

IIb/IIIainhibitor

10am14/1/07

11am14/1/07

2pm14/1/07

2.30pm14/1/07

Page 8: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ADJUNCTIVE THERAPY IN PCIADJUNCTIVE THERAPY IN PCI

45 year old male with chest painECG – T inversion V1 –V6

Troponin raised

Angiogram - 95% LAD stenosis

PCI to LAD

AspirinClopidogrelLMWH

?IIb/IIIa inhibitor

UFH

?IIb/IIIainhibitor

10am14/1/07

10am15/1/07

2pm18/1/07

2.30pm18/1/07

Page 9: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ACUITY STUDYACUITY STUDYDESIGNDESIGN

• 13,819 ACS patients13,819 ACS patients• 3 antithrombotic regimens3 antithrombotic regimens

- heparin + IIb/IIIa inhibitor- heparin + IIb/IIIa inhibitor- bivalirudin + IIb/IIIa - bivalirudin + IIb/IIIa

inhibitorinhibitor - bivalirudin alone - bivalirudin alone • Composite endpointComposite endpoint

- death/MI/unplanned revasc.- death/MI/unplanned revasc.- major bleeding- major bleeding

NEJM 2006;355:2203-16

Page 10: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ACUITY STUDYACUITY STUDYRESULTSRESULTS

HEPARIN +HEPARIN +IIb/IIIa INHIBITORIIb/IIIa INHIBITOR

BIVALIRUDIN +BIVALIRUDIN +IIB/IIIA INHIBITORIIB/IIIA INHIBITOR

COMPOSITECOMPOSITEISCHAEMIAISCHAEMIA

7.3%7.3% 7.7%7.7%

MAJORMAJORBLEEDINGBLEEDING

5.7%5.7% 5.3%5.3%

NET CLINICALNET CLINICALOUTCOMEOUTCOME

11.7%11.7% 11.8%11.8%

NEJM 2006:355:2203-16

Page 11: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ACUITYACUITY

But,

“Angiography was performed in 99% of patients at a median of 19.6 hours after admission……”

Page 12: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ISAR REACT 2ISAR REACT 2DesignDesign

• 2022 ACS patients2022 ACS patients• Pretreated with clopidogrel 600 mgPretreated with clopidogrel 600 mg• Randomised to abciximab or placeboRandomised to abciximab or placebo• Primary composite of death / MI / urgent TVRPrimary composite of death / MI / urgent TVR

JAMA 2006;295:1531-1538

Page 13: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ISAR REACT 2ISAR REACT 2Death / MI / urgent TVR at 30 daysDeath / MI / urgent TVR at 30 days

abciximababciximab placeboplacebo

No troponin elevationNo troponin elevation 4.6%4.6% 4.6%4.6%

Troponin elevationTroponin elevation 13.1%13.1% 18.3% **18.3% **

JAMA 2006;295:1531-1538

Page 14: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

“….recommended strategy was an early PCI with stenting within 6 hours from establishment of the diagnosis of ACS”

Page 15: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

ADJUNCTIVE THERAPY IN PCIADJUNCTIVE THERAPY IN PCI

45 year old male with chest painECG – T inversion V1 –V6

Troponin raised

Angiogram - 95% LAD stenosis

PCI to LAD

AspirinClopidogrelLMWH

?IIb/IIIa inhibitor

UFH

?IIb/IIIainhibitor

10am14/1/07

10am15/1/07

2pm18/1/07

2.30pm18/1/07

Page 16: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

SUMMARYSUMMARY

• STEMI STEMI - aspirin, clopidogrel, abciximab- aspirin, clopidogrel, abciximab• NSTEMINSTEMI - aspirin, clopidogrel, heparin for all- aspirin, clopidogrel, heparin for all

- add IIb/IIIa inhibitor if - add IIb/IIIa inhibitor if early early PCIPCI - - IIb/IIIa inhibitor for high risk PCIIIb/IIIa inhibitor for high risk PCI - - bivalirudin plus IIb/IIIa inhibitor is abivalirudin plus IIb/IIIa inhibitor is a possible possible alternative strategyalternative strategy

Page 17: The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007

The Leeds Teaching HospitalsNHS Trust

MY CONFLICTSOF INTEREST ARE:

Dr McLenachan is Clinical Director of Cardiologyat Leeds General Infirmary and is keen to save money by minimising the use of expensive drugs.